EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond anticoagulation: defining the role of left atrial appendage closure in stroke prevention for atrial fibrillation

A John Camm iD

Europace · 04.11.2026 · 28 (11)

DOI: 10.1093/europace/euag296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Europace, online erschienen am 06.11.2026. Verfasst von A John Camm. Beteiligte Einrichtung: Cardiovascular and Genomics Research Institute, School of Health & Medical Sciences, City St George's University of London, Tooting Campus, Cranmer T…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Left Atrial Appendage Closure, Stroke, Anticoagulants. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral anticoagulation has a very strong evidence base for stroke prevention in patients with atrial fibrillation (AF) at elevated thromboembolic risk. Direct oral anticoagulants have improved the safety and convenience of treatment, yet important limitations remain, including residual ischaemic stroke, major bleeding, treatment discontinuation, and patient refusal. Left atrial appendage closure (LAAC) offers an alternative strategy for selected patients by excluding the principal anatomical source of AF-related cardiac thrombi. However, the appropriate role of LAAC remains controversial, particularly in patients who can and do tolerate anticoagulation. This viewpoint argues for a more individualized approach that distinguishes absolute contraindications from modifiable bleeding risks, treatment refusal or non-persistence, and stroke occurring despite adequate anticoagulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationLeft Atrial Appendage ClosureStrokeAnticoagulantsAtrial AppendageHumansRisk FactorsTreatment OutcomeHemorrhageAdministration, OralRisk Assessment

Stichwörter der Autor:innen

Anticoagulation failureAtrial fibrillationBleedingDirect oral anticoagulantsLeft atrial appendage closureStroke prevention

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Cardiovascular and Genomics Research Institute, School of Health & Medical Sciences, City St George's University of London, Tooting Campus, Cranmer Terrace, London SW17 0RE, UK.

ORCID-Profile: A John Camm

Zitieren

APA

Camm, A. J. (2026). Beyond anticoagulation: defining the role of left atrial appendage closure in stroke prevention for atrial fibrillation. Europace, 28(11). https://doi.org/10.1093/europace/euag296

Vancouver

Camm AJ. Beyond anticoagulation: defining the role of left atrial appendage closure in stroke prevention for atrial fibrillation. Europace. 2026;28(11). doi:10.1093/europace/euag296

BibTeX
@article{Camm2026,
  author = {Camm, A John},
  title = {Beyond anticoagulation: defining the role of left atrial appendage closure in stroke prevention for atrial fibrillation},
  journal = {Europace},
  year = {2026},
  volume = {28},
  number = {11},
  doi = {10.1093/europace/euag296}
}
Kostenlos starten →